Onkologie. 2020:14(4):178-181 | DOI: 10.36290/xon.2020.062
The complexity of oncological treatment has resulted in an effort towards high individualization and rational use. Indeed, advanced molecular analyses of tumour and non-tumour tissues are being used more increasingly and should help us achieve this individualization. Particularly in terms of newly introduced medicinal products in the form of targeted (biological) therapy and immunotherapy, some types of molecular test are even required. Sometimes, we can perform testing above and beyond our normal obligations and bring additional variants in the treatment algorithm of a cancer patient. So, what are the options of molecular analyses in clinical oncological practice in the Czech Republic
Published: September 23, 2020 Show citation